Clinical Trials Directory

Trials / Terminated

TerminatedNCT02802033

A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders

DegenPRO: A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders

Status
Terminated
Phase
Study type
Observational
Enrollment
908 (actual)
Sponsor
AO Innovation Translation Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Details regarding the degenerative spine disorders will be collected with a specific focus on the use of osteobiologics in treating degenerative conditions and their impact on fusion, as well as patient-reported outcomes for these conditions.

Detailed description

The registry is designed to be open-ended. However, a statistical evaluation of the content und structure of database and CRFs in order to investigate the feasibility and quality of data collection is planned to take place prior to the registry expansion. Variables applicable to patients with a degenerative spine disorder which will be collected in the registry include: * Patient details * Symptoms * Diagnosis * Imaging assessment * Treatment details Feasibility phase: The statistical evaluation of the feasibility and quality of data collection will be performed after the first 5 sites have each enrolled 12 patients with a degenerative pathology and documented one follow-up visit. During this evaluation, enrolment of further patients can be continued. Based on the findings of this feasibility phase, adjustments to the existing database can be performed before the registry is rolled out on larger scale. Registry expansion: Following the evaluation process of the feasibility phase, the registry will be expanded to allow data entry in more sites globally. Multi-site participation of this registry will be rolled-out in stages, and will be offered to sites with appropriate expertise which are selected based on their potential (interest, resources and expected patient volume).

Conditions

Timeline

Start date
2016-01-01
Primary completion
2025-01-31
Completion
2025-01-31
First posted
2016-06-16
Last updated
2026-04-13

Locations

7 sites across 3 countries: United States, Germany, Italy

Source: ClinicalTrials.gov record NCT02802033. Inclusion in this directory is not an endorsement.